رجوع
35
نطاق اليوم
KWD 0.27
KWD 0.27
نطاق 52 أسبوعًا
KWD 0.24
KWD 0.35
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 0.27
/
KWD 0.27
الإغلاق السابق
KWD 0.27
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -4.1 | 0.4 |
| P/B | 0.1 | 2.9 |
| ROE % | -1.6 | 3.7 |
| Net Margin % | -2.3 | 3.8 |
| Rev Growth 5Y % | -6.8 | 10.0 |
| D/E | 0.1 | 0.2 |
النقاط الرئيسية
Revenue declined -6.82% annually over 5 years
Earnings declined -716.35% over the past year
Debt/Equity of 0.12 — conservative balance sheet
Generating 2.07B in free cash flow
PEG of 0.04 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.17%
النمو
Revenue Growth (5Y)
-6.82%
Revenue (1Y)-12.99%
Earnings (1Y)-716.35%
FCF Growth (3Y)91.45%
الجودة
Return on Equity
-1.60%
ROIC0.97%
Net Margin-2.32%
Op. Margin2.07%
الأمان
Debt / Equity
0.12
Current Ratio2.29
Interest Coverage3.08
التقييم
P/E Ratio
-4.13
P/B Ratio0.07
EV/EBITDA-0.59
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12.99% | Revenue Growth (3Y) | -10.97% |
| Earnings Growth (1Y) | -716.35% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.36B | Net Income (TTM) | -333.24M |
| ROE | -1.60% | ROA | -1.03% |
| Gross Margin | 48.09% | Operating Margin | 2.07% |
| Net Margin | -2.32% | Free Cash Flow (TTM) | 2.07B |
| ROIC | 0.97% | FCF Growth (3Y) | 91.45% |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 2.29 |
| Interest Coverage | 3.08 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | -4.13 | P/B Ratio | 0.07 |
| P/S Ratio | 0.10 | PEG Ratio | 0.04 |
| EV/EBITDA | -0.59 | Dividend Yield | 0.04% |
| Market Cap | 1.38B | Enterprise Value | -175.02M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.36B | 16.51B | 18.12B | 14.30B | 19.05B |
| Net Income | -333.24M | 54.07M | 1.29B | 764.49M | 1.93B |
| EPS (Diluted) | -0.07 | 0.01 | 0.26 | 0.15 | 0.38 |
| Gross Profit | 6.91B | 7.86B | 9.27B | 7.20B | 11.83B |
| Operating Income | 297.75M | 335.59M | 1.43B | 1.06B | 2.75B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32.36B | 35.06B | 37.07B | 35.62B | 36.39B |
| Total Liabilities | 8.94B | 11.13B | 13.13B | 12.67B | 13.73B |
| Shareholders' Equity | 20.48B | 21.20B | 21.16B | 20.17B | 19.72B |
| Total Debt | 2.49B | 4.02B | 5.16B | 5.04B | 5.06B |
| Cash & Equivalents | 4.05B | 3.87B | 3.02B | 3.07B | 2.89B |
| Current Assets | 17.72B | 18.84B | 19.80B | 17.97B | 18.20B |
| Current Liabilities | 7.74B | 7.80B | 9.33B | 10.10B | 8.76B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#565 of 820
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026